Authors:
Eisenbud, R
Assmann, SF
Kalish, LA
van der Horst, C
Collier, AC
Citation: R. Eisenbud et al., Differences difficulty adjudicating clinical events in patients with advanced HIV disease, J ACQ IMM D, 28(1), 2001, pp. 43-46
Authors:
Para, MF
Kalish, LA
Collier, AC
Pollard, RB
Kumar, PN
Mintz, L
Wallach, FR
Drew, WL
Citation: Mf. Para et al., Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions, J ACQ IMM D, 26(4), 2001, pp. 320-325
Authors:
Collier, AC
Kalish, LA
Busch, MP
Gernsheimer, T
Assmann, SF
Lane, TA
Asmuth, DM
Lederman, MM
Murphy, EL
Kumar, P
Kelley, M
Flanigan, TP
McMahon, DK
Sacks, HS
Kennedy, MS
Holland, PV
Citation: Ac. Collier et al., Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection - The viral activation transfusion study: A randomized controlled trial, J AM MED A, 285(12), 2001, pp. 1592-1601
Authors:
Mohr, BA
Feldman, HA
Kalish, LA
Longcope, C
McKinlay, JB
Citation: Ba. Mohr et al., Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study, UROLOGY, 57(5), 2001, pp. 930-935
Authors:
Yomtovian, R
Gernsheimer, T
Assmann, SF
Mohandas, K
Lee, TH
Kalish, LA
Busch, MP
Citation: R. Yomtovian et al., WBC reduction in RBC concentrates by prestorage filtration: multicenter experience, TRANSFUSION, 41(8), 2001, pp. 1030-1036
Authors:
Para, MF
Kalish, LA
Collier, AC
Murphy, EL
Drew, WL
Citation: Mf. Para et al., Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion, J INFEC DIS, 183(11), 2001, pp. 1673-1677
Authors:
Murphy, EL
Collier, AC
Kalish, LA
Assmann, SF
Para, MF
Flanigan, TP
Kumar, PN
Mintz, L
Wallach, FR
Nemo, GJ
Citation: El. Murphy et al., Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease, ANN INT MED, 135(1), 2001, pp. 17-26
Authors:
Lederman, MM
Kalish, LA
Asmuth, D
Fiebig, E
Mileno, M
Busch, MP
Citation: Mm. Lederman et al., 'Modeling' relationships among HIV-1 replication, immune activation and CD4+T-cell losses using adjusted correlative analyses, AIDS, 14(8), 2000, pp. 951-958
Authors:
Anastos, K
Kalish, LA
Hessol, N
Weiser, B
Melnick, S
Burns, D
Delapenha, R
DeHovitz, J
Cohen, M
Meyer, W
Bremer, J
Kovacs, A
Citation: K. Anastos et al., The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study (vol 13, pg 1717, 1999), AIDS, 14(7), 2000, pp. 891-891
Authors:
Dunn, DT
Simonds, RJ
Bulterys, M
Kalish, LA
Moye, J
de Maria, A
Kind, C
Rudin, C
Denamur, E
Krivine, A
Loveday, C
Newell, ML
Citation: Dt. Dunn et al., Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples, AIDS, 14(10), 2000, pp. 1421-1428
Authors:
Kalish, LA
Collier, AC
Flanigan, TP
Kumar, PN
Citation: La. Kalish et al., Plasma human immunodeficiency virus (HIV) type 1 RNA load in men and womenwith advanced HIV-1 disease, J INFEC DIS, 182(2), 2000, pp. 603-606
Authors:
Palefsky, JM
Minkoff, H
Kalish, LA
Levine, A
Sacks, HS
Garcia, P
Young, M
Melnick, S
Miotti, P
Burk, R
Citation: Jm. Palefsky et al., Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women, J NAT CANC, 91(3), 1999, pp. 226-236
Authors:
Anastos, K
Kalish, LA
Palacio, H
Benson, CA
Delapenha, R
Chirgwin, K
Stonis, L
Telzak, EE
Citation: K. Anastos et al., Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women, J ACQ IMM D, 21(2), 1999, pp. 141-147
Authors:
Hanson, IC
Antonelli, TA
Sperling, RS
Oleske, JM
Cooper, E
Culnane, M
Fowler, MG
Kalish, LA
Lee, SS
McSherry, G
Mofenson, L
Shapiro, DE
Citation: Ic. Hanson et al., Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatalexposure to zidovudine, J ACQ IMM D, 20(5), 1999, pp. 463-467
Authors:
Anastos, K
Kalish, LA
Hessol, N
Weiser, B
Melnick, S
Burns, D
Delapenha, R
DeHovitz, J
Cohen, M
Meyer, W
Bremer, J
Kovacs, A
Citation: K. Anastos et al., The relative value od CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study, AIDS, 13(13), 1999, pp. 1717-1726
Citation: La. Kalish et Jb. Mckinlay, Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: Age-specific reference ranges for total PSA, free PSA, and percent free PSA, UROLOGY, 54(6), 1999, pp. 1022-1027
Authors:
Garcia, PM
Kalish, LA
Pitt, J
Minkoff, H
Quinn, TC
Burchett, SK
Kornegay, J
Jackson, B
Moye, J
Hanson, C
Zorrilla, C
Lew, JF
Citation: Pm. Garcia et al., Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission, N ENG J MED, 341(6), 1999, pp. 394-402
Authors:
Kalish, LA
McIntosh, K
Read, JS
Diaz, C
Landesman, SH
Pitt, J
Rich, KC
Shearer, WT
Davenny, K
Lew, JF
Citation: La. Kalish et al., Evaluation of human immunodeficiency virus (HIV) type 1 load, CD4 T cell level, and clinical class as time-fixed and time-varying markers of disease progression in HIV-1 - Infected children, J INFEC DIS, 180(5), 1999, pp. 1514-1520
Authors:
Telzak, EE
Hershow, R
Kalish, LA
Hardy, WD
Zuckerman, E
Levine, A
Delapenha, R
DeHovitz, J
Greenblatt, RM
Anastos, K
Citation: Ee. Telzak et al., Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection, J ACQ IMM D, 19(5), 1998, pp. 513-518
Authors:
Hershow, RC
Kalish, LA
Sha, B
Till, M
Cohen, M
Citation: Rc. Hershow et al., Hepatitis C virus infection in Chicago women with or at risk for HIV infection - Evidence for sexual transmission, SEX TRA DIS, 25(10), 1998, pp. 527-532